Fascial Therapy in Elbow Hemophilic Arthropathy
Кључне речи
Апстрактан
Датуми
| Последња верификација: | 01/31/2019 |
| Фирст Субмиттед: | 12/29/2016 |
| Предвиђена пријава послата: | 12/29/2016 |
| Прво објављено: | 01/03/2017 |
| Послато последње ажурирање: | 02/24/2019 |
| Последње ажурирање објављено: | 02/25/2019 |
| Стварни датум почетка студије: | 02/11/2018 |
| Процењени датум примарног завршетка: | 11/30/2018 |
| Предвиђени датум завршетка студије: | 02/14/2019 |
Стање или болест
Интервенција / лечење
Other: Expermiental group
Фаза
Групе руку
| Арм | Интервенција / лечење |
|---|---|
| Experimental: Expermiental group All patients included in the experimental group should be on prophylactic treatment with FVIII / FIX concentrates. Likewise, the factor should be administered on the same day that they receive each of the fascial therapy treatment sessions. Each session will last approximately 50 minutes, with three physiotherapy sessions taking place over a period of 3 weeks. The treatment program includes 11 maneuvers that must be administered bilaterally: | Other: Expermiental group Longitudinal surface sliding maneuver over the superficial fascia in the anterior region of the arm and the forearm. Applied in 3 strokes.
Transverse sliding of the flexor muscles of the wrist and fingers.
Transverse sliding for the biceps brachii muscle.
Longitudinal surface sliding over the superficial fascia in the posterior arm region.
Transverse sliding over the brachial triceps tendon.
Transverse sliding for the pectoralis major muscle.
Transverse sliding for the posterior axillary region pectoralis major muscle.
Induction of the posterior axillary fold.
Induction (crossed hands over the brachial region and forearm).
Maneuver of transverse planes for the cervicothoracic region.
Upper limb telescopic maneuver. |
| No Intervention: Control group Subjects included in the control group will not receive physical therapy through fascial therapy and will continue with their usual routine of physical activity and exercise, and with the same pharmacological treatment regimen with FVIII / FIX. At the end of the study period the intervention will be applied under the same conditions as the experimental group, analyzing the overall sample at the end of the study. |
Критеријуми
| Узраст подобан за студирање | 18 Years До 18 Years |
| Полови подобни за студирање | Male |
| Прихвата здраве волонтере | да |
| Критеријуми | Inclusion Criteria: - Patients diagnosed with hemophilia A and B - Patients adults (over 18 years) - Patients diagnosed with hemophilic arthropathy of the elbow (by clinical assessment with the Hemophilia Joint Health Score) - Patients pn prophylactic treatment with FVIII / FIX concentrates. Exclusion Criteria: - Patients without ambulation ability - Patients with inhibitors - Patients with neurological or cognitive alterations that impede the comprehension of the questionnaires and physical tests - Patients who have not signed the informed consent document. |
Исход
Примарне мере исхода
1. Change from baseline elbow joint bleeding frequency after treatment and at 3 months [Screening visit, within the first seven days after treatment and after three months follow-up visit]
Секундарне мере исхода
1. Change from baseline range of motion of elbow after treatment and at 3 months [Screening visit, within the first seven days after treatment and after three months follow-up visit]
2. Change from baseline elbow joint status after treatment and at 3 months [Screening visit, within the first seven days after treatment and after three months follow-up visit]
3. Change from baseline joint pain of elbow after treatment and at 3 months [Screening visit, within the first seven days after treatment and after three months follow-up visit]
4. Change from baseline upper limb functionality after treatment and at 3 months [Screening visit, within the first seven days after treatment and after three months follow-up visit]
5. Change from baseline quality of life after treatment and at 3 months [Screening visit, within the first seven days after treatment and after three months follow-up visit]
